China Pharma Holdings (CPHI) EPS (Basic) (2011 - 2026)
China Pharma Holdings (CPHI) posted EPS (Basic) of -$0.04 for Q1 2026, up 84.32% on a QoQ basis from -$0.28 in Q4 2025, and up 81.46% year-over-year from -$0.02 in Q1 2025.
China Pharma Holdings (CPHI) EPS (Basic) (2011 - 2026) Analysis & Trends
China Pharma Holdings' EPS (Basic) history runs 16 years deep, the most recent figure standing at -$0.04 for Q1 2026.
- Quarterly EPS (Basic) rose 81.46% year-over-year to -$0.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.14 (up 90.11% YoY) and the FY2025 annual result came in at -$0.56, up 72.61% from the prior year.
- EPS (Basic) was -$0.04 for Q1 2026 at China Pharma Holdings, up from -$0.28 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.04 in Q1 2026 and bottomed at -$12.02 in Q4 2022.
- A 5-year average of -$3.31 and a median of -$0.89 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) decreased 29.1% — and 2025, when it surged 81.84%.
- China Pharma Holdings' EPS (Basic) stood at -$12.02 in 2022, then surged by 69.71% to -$3.64 in 2023, then soared by 80.75% to -$0.7 in 2024, then surged by 59.38% to -$0.28 in 2025, then soared by 84.32% to -$0.04 in 2026.
- Business Quant data shows CPHI's EPS (Basic) at -$0.04 in Q1 2026, -$0.28 in Q4 2025, and -$0.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.16 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.70 |
| Sep 30, 2024 | -0.65 |
| Jun 30, 2024 | -0.89 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | -3.64 |
| Sep 30, 2023 | -2.94 |
| Jun 30, 2023 | -2.99 |
| Mar 31, 2023 | -2.95 |
| Dec 31, 2022 | -12.02 |
| Sep 30, 2022 | -7.91 |
| Jun 30, 2022 | -9.16 |
| Mar 31, 2022 | -10.87 |
| Dec 31, 2021 | -10.63 |
| Sep 30, 2021 | -8.99 |
| Jun 30, 2021 | -9.05 |